Pharmaceuticals & Therapeutics

A new report reveals how GLP-1 drugs are accelerating a major healthcare shift in the Gulf, turning metabolic health into a core economic and policy issue.

The UK-based firm's STIMULAN® is now the only EU-certified calcium matrix for combined antibiotic use, revolutionizing bone infection treatment.

Pharmaceutical giant Fagron expands into packaging in Brazil and raw materials in Hungary, fortifying its end-to-end personalized medicine supply chain.

A new hybrid exhibition model connects global buyers with Asian smart medical innovators for an unprecedented four-month period, signaling a major shift.

The world's largest jeweler misses 2025 growth targets and issues a sober 2026 forecast, prompting a major strategic shift to platinum-plated jewelry.

With battery and solar costs plummeting, a new era of sustainable energy is dawning—driven by profit, not just policy. Here's the roadmap.

Global construction costs are climbing, but a new report warns that unpredictable market volatility, not inflation, is the true threat to project delivery.

A new packaging board from Emerald Ecovations uses sugarcane waste to help CPG brands ditch plastic and deforestation amid intense consumer pressure.

A nationwide study, with NFL legend Steve Gleason as Participant #1, seeks to uncover why high-performance groups face a disproportionate risk of ALS.

A breakthrough program at Children's Hospital of Philadelphia is redefining heart pumps as tools for recovery, not just a bridge to transplant.

With two new high-profile hires, Ursa Major is pivoting from R&D to mass production, aiming to fix critical gaps in the US defense supply chain.

Lummus and Sumitomo launch a breakthrough recycling process for PMMA plastic, promising a 50% emissions cut and a circular future for key industries.

With a fresh capital infusion extending its runway into 2027, GRI Bio pushes ahead with promising clinical data for its IPF and autoimmune disease pipeline.

A world-first trial for personalized mRNA vaccines offers new hope for children with aggressive brain tumors, a mission born from a father's own fight.

An exclusive FDA invite positions IKE Tech’s blockchain-based age-gating system at the heart of future vape regulation, a move that could redefine the industry.

Beyond Cancer is set to reveal early human trial data for its novel nitric oxide therapy, a move that could expand its parent company into oncology.

As Aspen Aerogels prepares its Q4 results, investors weigh a challenging 2025 against a booming aerogel market and future EV growth prospects.

KLAS Research honors uPerform in a new award category, reflecting a critical industry shift where workforce training is now a core strategic priority.

With key data on its Duchenne muscular dystrophy drugs expected in 2026, Entrada's CEO Dipal Doshi will detail the firm's high-risk, high-reward strategy.

With $125M in new funding from steel and cement makers, newcleo accelerates its plan to turn nuclear waste into clean energy for heavy industry.